285 related articles for article (PubMed ID: 10492107)
1. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
Spencer C; Crook D; Ross D; Cooper A; Whitehead M; Stevenson J
Br J Obstet Gynaecol; 1999 Sep; 106(9):948-53. PubMed ID: 10492107
[TBL] [Abstract][Full Text] [Related]
2. Effects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women.
Sendag F; Karadadas N; Ozsener S; Bilgin O
Arch Gynecol Obstet; 2002 Jan; 266(1):38-43. PubMed ID: 11998963
[TBL] [Abstract][Full Text] [Related]
3. Effects of transdermal 17 beta-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal women.
Słowińska-Srzednicka J; Zgliczyński S; Chotkowska E; Srzednicki M; Stopińska-Głuszak U; Jeske W; Brzezińska A; Zgliczyński W; Sadowski Z
J Intern Med; 1993 Nov; 234(5):447-51. PubMed ID: 7693846
[TBL] [Abstract][Full Text] [Related]
4. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
5. Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate.
Owens D; Collins PB; Johnson A; Tomkin GH
Diabet Med; 2000 Apr; 17(4):308-15. PubMed ID: 10821298
[TBL] [Abstract][Full Text] [Related]
6. The effect of hormone replacement therapy on the oxidation of low density lipoprotein in postmenopausal women.
Mc Manus J; Mc Eneny J; Thompson W; Young IS
Atherosclerosis; 1997 Nov; 135(1):73-81. PubMed ID: 9395275
[TBL] [Abstract][Full Text] [Related]
7. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.
Farish E; Spowart K; Barnes JF; Fletcher CD; Calder A; Brown A; Hart DM
Atherosclerosis; 1996 Sep; 126(1):77-84. PubMed ID: 8879436
[TBL] [Abstract][Full Text] [Related]
8. Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.
Samsioe G; Li C; Borgfeldt C; Wilawan K; Aberg A; Larsen S
Menopause; 2002; 9(5):335-42. PubMed ID: 12218722
[TBL] [Abstract][Full Text] [Related]
9. Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial.
Kotecha PT; Godsland IF; Crook D; Stevenson JC
Clin Endocrinol (Oxf); 2020 Apr; 92(4):303-311. PubMed ID: 31925799
[TBL] [Abstract][Full Text] [Related]
10. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Ylikorkala O; Lim P; Caubel P
Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women.
Al-Azzawi F; Wahab M; Sami S; Proudler AJ; Thompson J; Stevenson J
Climacteric; 2004 Sep; 7(3):292-300. PubMed ID: 15669554
[TBL] [Abstract][Full Text] [Related]
12. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women.
Laivuori H; Koistinen HA; Karonen SL; Cacciatore B; Ylikorkala O
Hum Reprod; 2001 Aug; 16(8):1632-5. PubMed ID: 11473954
[TBL] [Abstract][Full Text] [Related]
13. Long-term influence of different postmenopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study.
Hänggi W; Lippuner K; Riesen W; Jaeger P; Birkhäuser MH
Br J Obstet Gynaecol; 1997 Jun; 104(6):708-17. PubMed ID: 9197875
[TBL] [Abstract][Full Text] [Related]
14. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
Taskinen MR; Puolakka J; Pyörälä T; Luotola H; Bjäörn M; Kääriänen J; Lahdenperä S; Ehnholm C
Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1215-21. PubMed ID: 8857916
[TBL] [Abstract][Full Text] [Related]
16. The effect of transdermal 17β-estradiol combined with norethisterone acetate treatment on the lipid profile in postmenopausal women: A meta-analysis and systematic review of randomized controlled trials.
Tao W; Cai X; Al Masri MK; Găman MA; Prabahar K; Baradwan S; Mao P
Steroids; 2022 Sep; 185():109061. PubMed ID: 35688182
[TBL] [Abstract][Full Text] [Related]
17. The influence of transdermal oestradiol replacement therapy and medroxyprogesterone acetate on serum lipids and lipoproteins.
Bhathena RK; Anklesaria BS; Ganatra AM; Pinto R
Br J Clin Pharmacol; 1998 Feb; 45(2):170-2. PubMed ID: 9491833
[TBL] [Abstract][Full Text] [Related]
18. Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women.
Jensen J; Christiansen C
Maturitas; 1987 Nov; 9(3):259-66. PubMed ID: 3323852
[TBL] [Abstract][Full Text] [Related]
19. Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate.
Campagnoli C; Colombo P; De Aloysio D; Gambacciani M; Grazioli I; Nappi C; Serra GB; Genazzani AR
Maturitas; 2002 Apr; 41(4):299-311. PubMed ID: 12034517
[TBL] [Abstract][Full Text] [Related]
20. Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device.
Raudaskoski TH; Tomás EI; Paakkari IA; Kauppila AJ; Laatikainen TJ
Maturitas; 1995 Jun; 22(1):47-53. PubMed ID: 7666816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
